APMD — Apnimed, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1745648 ·
Last close
$17.80
Market Cap
$741.03M
52W High
$35.29
52W Low
$13.88
ADV30
388,304
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 12,080,000 10,870,000 -11,704,000 125,935,000 195,456,000 172,804,000 371,637,000
Mar 2026 84,814,000 82,654,000 68,044,000 70,373,000 342,634,000 328,884,000 85,044,000
Jun 2025 17,110,000 15,386,000 -5,936,000 -69,474,000 — — —
Mar 2025 3,131,000 1,814,000 -27,112,000 -28,646,000 — — —

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-83,747,000
Investing CF
—
Financing CF
$85,468,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.87
As of
2026-09-13

Balance + Analyst (yfinance extras)

Retained Earnings
$-203,690,000
Inventory
—
Receivables
$690,000
ST Investments
—
EBIT TTM
$23,292,000
Pretax Income TTM
$164,178,000
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$115,120,000
EBITDA
$35,897,000
Free Cash Flow
—
Enterprise Value
$929,897,024
Total Cash
$172,804,000
Total Debt
$80,348,000
Shares Out
41,630,779
Trailing EPS
$7.22
Book Value
$-36.69
ROE
—
ROA
—
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 38,467,000 -53,818,000 -932,000 72,873,000 445,656,000 -372,783,000 -77,832,000
Dec 2024 8,012,000 -114,234,000 -111,305,000 109,223,000 357,838,000 -248,615,000 -110,209,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$195,456,000
Forward EPS
$-3.98

Peers — same industry

TickerNameMarket CapLastDaily %
PAHC PHIBRO ANIMAL HEALTH CORP $737.01M $34.92 —
OBX Obsidian Therapeutics, Inc. $745.61M $12.07 —
IVEVF Inventiva S.A. $751.18M $3.18 —
IVA Inventiva S.A. $760.63M $3.22 —
SGMT Sagimet Biosciences Inc. $702.97M $9.85 —

News headlines (Yahoo Finance, 1h cache)

Apnimed Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-16 13:00 · Yahoo
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2026-11-05 21:05 · Yahoo
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
2026-10-12 20:05 · Yahoo
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-09-08 20:39 · Yahoo
BofA makes bullish call on newly public biotech stock
2026-08-29 01:03 · Yahoo
Apnimed shares surge on bullish BofA initiation
2026-08-25 16:12 · Yahoo
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
2026-10-15 07:30 · Yahoo
Bank of America Puts These 2 Under-the-Radar IPO Stocks on Its Buy List
2026-10-06 17:58 · Yahoo
Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
2026-09-22 17:39 · Yahoo
Moderna Stock Carries A Market Value Its Revenue Does Not Support
2026-08-26 15:13 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.